Clinical Trials Logo

Clinical Trial Summary

The goal of this clinical trial is to compare 2 different timepoints for clamping the umbilical cord at birth for term-born infants with a prenatal diagnosis of congenital heart disease (CHD). The main questions it aims to answer are: - Does Delayed Cord Clamping at 120 seconds (DCC-120) or Delayed Cord Clamping at 30 seconds (DCC-30) after birth lead to better health outcomes? - Does DCC-120 seconds or DCC-30 seconds after birth lead to better neuromotor outcomes at 22-26 months of infant age (postnatal)? Participants will be asked to do the following: - Participate in either DCC-120 or DCC-30 at birth (randomized assignment). - Complete General Movements Assessment (GMA) at 3-4 months of infant age (postnatal), complete questionnaires / surveys at this time. - Complete questionnaires / surveys at 9-12 months of infant age (postnatal). - Complete Hammersmith Infant Neurological Examination (HINE), Developmental Assessment of Young Children 2 Edition (DAYC-2), and questionnaires / surveys at 22-26 months of infant age (postnatal). - Permit data collection from electronic medical records for both the mother and infant study participants. Investigators will compare DCC-120 vs. DCC-30 to see which approach is more beneficial to both the mother and baby with CHD.


Clinical Trial Description

- AIM 1: Test the hypothesis that, among neonates with prenatally diagnosed significant CHD (ranking of 3 - 6 on the Fetal Cardiovascular Disease Severity Score [FCDSS]), DCC-120 results in lower global rank score (GRS), indicative of better health outcomes, compared with DCC-30. - AIM 2: Test the hypothesis that, among neonates with prenatally diagnosed significant CHD (ranking from 3 - 6 on the Fetal Cardiovascular Disease Severity Score [FCDSS]), DCC-120 will result in better neuromotor outcomes at 22-26 months postnatal than DCC-30. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06153459
Study type Interventional
Source Nationwide Children's Hospital
Contact Carl Backes, MD
Phone 614-355-6729
Email carl.backes@nationwidechildrens.org
Status Recruiting
Phase N/A
Start date December 19, 2023
Completion date December 2030

See also
  Status Clinical Trial Phase
Terminated NCT02952287 - Assessment of Flow With the New Four-dimensional Velocity-encoded Magnetic Resonance Imaging Technique N/A
Active, not recruiting NCT04236479 - Mesenchymal Stromal Cells for Infants With Congenital Heart Disease (MedCaP) Phase 1
Completed NCT02644824 - Biventricular Pacing in Children With Congenital Heart Disease N/A
Completed NCT02806245 - Biventricular Pacing in Children After Surgery for Congenital Heart Disease N/A
Recruiting NCT02303535 - National Congenital Heart Disease Audit N/A